Clinical Trials Directory

Trials / Completed

CompletedNCT02573792

Optical Coherence Tomography and Optic Neuritis (OCTON)

Optical Coherence Tomography for the Etiological Diagnosis of Inflammatory Optic Neuritis

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Optic neuritis (ON) can remain isolated or reveal a widespread and chronic disease of the central nervous system (CNS), a multiple sclerosis (MS) or, more rarely, a Devic's neuromyelitis optica (NMO) or a systemic disease. The optical coherence tomography (OCT) is a retinal imaging technique to measure the thickness of the retina and its different layers with an accuracy of 4-6 µM. Costello et al have shown that approximately 75% of 54 MS patients have developed within 3 to 6 months after a ON a loss of 10 to 40 µM in the thickness of the peripapillary retinal nerve fiber layer (RNFL). The etiologic diagnosis of ON has been transformed in recent years. MS can now be diagnosed by McDonald's MRI criteria and NMO by the AQP4 antibodies (anti-aquaporin- 4) antibodies and the anti-MOG (myelin-oligodendrocyte glycoprotein) antibodies. The diagnosis and prognosis value of the OCT in patients with ON is not well known

Conditions

Timeline

Start date
2015-10-05
Primary completion
2019-07-01
Completion
2019-07-01
First posted
2015-10-12
Last updated
2021-06-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02573792. Inclusion in this directory is not an endorsement.

Optical Coherence Tomography and Optic Neuritis (OCTON) (NCT02573792) · Clinical Trials Directory